FDA to use enforcement discretion on whole-grains health claims

The FDA says there is limited evidence to support health claims that whole-grain consumption can reduce diabetes risk, and that it will use its enforcement discretion for two food-label claims that whole grains may reduce the risk of type 2 diabetes. Food manufacturers are permitted to make the claims if they are worded in a manner that does not mislead consumers.

View Full Article in:

FoodBusinessNews.net (free registration) · CandyAndSnackToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA